Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-valvular Atrial Fibrillation (NVAF)”

67 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 67 results

Post-approval studies (Phase 4)Study completedNCT01493557
What this trial is testing

A Prospective, Open Label Study Evaluating Two Management Strategies on Gastrointestinal Symptoms in Patients Newly on Treatment With Pradaxa for the Prevention of Stroke and Systemic Embolism With Non-valvular Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Boehringer Ingelheim 1,067
Not applicableStudy completedNCT02502396
What this trial is testing

Rivaroxaban Utilization for Treatment and Prevention of Thromboembolism in Cancer Patients: Experience at a Comprehensive Cancer Center

Who this might be right for
CancerDeep-vein Thrombosis of the Lower and Upper ExtremitiesPulmonary Embolism+1 more
M.D. Anderson Cancer Center 265
Not applicableStudy completedNCT01598051
What this trial is testing

Xarelto [SPAF-QOL] Post-marketing Surveillance in Japan

Who this might be right for
Non-valvular Atrial Fibrillation (NVAF)
Bayer 741
Not applicableStudy completedNCT05471505
What this trial is testing

Safety and Effectiveness of Apixaban Compared to Warfarin in Patients With Non-valvular Atrial Fibrillation (a Type of Irregular Heart Rhythm) at Higher Chance of Bleeding

Who this might be right for
Non-valvular Atrial Fibrillation
Pfizer 120,722
Not applicableStudy completedNCT04174859
What this trial is testing

Study Aims to Collect Information in Routine Clinical Practice in Italy About the Number of Patients Suffering From Irregularly Heart Beats Which Are Not Caused by a Heart Valve Problem (Non-valvular Atrial Fibrillation, NVAF) Who Stopped or Changed Rivaroxaban Treatment

Who this might be right for
Non-valvular Atrial Fibrillation
Bayer 812
Not applicableEnded earlyNCT06189365
What this trial is testing

Amplatzer Amulet China Post Market Study (PMS)

Who this might be right for
Non-Valvular Atrial Fibrillation
Abbott Medical Devices 50
Not applicableStudy completedNCT03887780
What this trial is testing

Evaluate the Safety and Effectiveness of Rivaroxaban (Xarelto) for Prevention of Stroke and Systemic Embolism in Indian Patients With Non-valvular Atrial Fibrillation (NVAF)

Who this might be right for
Non-valvular Atrial Fibrillation (NVAF)
Bayer 504
Not applicableStudy completedNCT05022758
What this trial is testing

Learn Whether There Are Differences in the Kidney's Ability to Work Properly in Korean Patients With Non-valvular Atrial Fibrillation (Irregular and Often Rapid Heartbeat Not Caused by a Heart Valve Problem) Treated With Rivaroxaban as Compared to Those Treated With Warfarin

Who this might be right for
Non-valvular Atrial Fibrillation (NVAF)
Bayer 45,000
Not applicableStudy completedNCT04234698
What this trial is testing

Patient Characteristics, Treatment Patterns And Incidence Of Events (Discontinuation, Persistence, Key Primary Clinical Outcomes) In NVAF Patients Initiating OAC Therapy In Colombia

Who this might be right for
Atrial Fibrillation
Pfizer 2,076
Not applicableUnknownNCT06058130
What this trial is testing

Combination of Antiplatelet and Anticoagulation for AIS Patients Witn Concomitant NVAF and Extracranial/Intracranial Artery Stenosis

Who this might be right for
Acute Ischemic StrokeAtrial FibrillationStenosis, Carotid+1 more
Second Affiliated Hospital, Zhejiang University, School of Medicine 2,171
Not applicableEnrolling By InvitationNCT07654634
What this trial is testing

Precision Antithrombotic Therapy

Who this might be right for
Non-valvular Atrial Fibrillation (NVAF)Venous Thromboembolism (VTE)MI(Myocardial Infarction)+1 more
The Third Xiangya Hospital of Central South University 5,000
Not applicableStudy completedNCT04509193
What this trial is testing

A Study Using Electronic Health Information to Learn About Rivaroxaban Compared to Warfarin in Participants With Non-valvular Atrial Fibrillation (NVAF) and Diabetes

Who this might be right for
Atrial Fibrillation
Bayer 116,049
Post-approval studies (Phase 4)Study completedNCT01896297
What this trial is testing

Pradaxa Study in Non-valvular Atrial Fibrillation Patients With Severely Impaired Renal Function

Who this might be right for
Atrial Fibrillation
Boehringer Ingelheim 63
Not applicableStudy completedNCT02960880
What this trial is testing

Real-world Comparative Effectiveness of Stroke Prevention in Patients With Atrial Fibrillation Treated With Rivaroxaban vs. Vitamin k Antagonists

Who this might be right for
Atrial Fibrillation
Bayer 99,999
Not applicableStudy completedNCT02061748
What this trial is testing

The Comparative Safety and Effectiveness of Warfarin and Dabigatran Prescribed in the Non-valvular Atrial Fibrillation Population With Humana Healthcare Coverage

Who this might be right for
Atrial Fibrillation
Boehringer Ingelheim 38,499
Not applicableStudy completedNCT02043808
What this trial is testing

The Safety and Effectiveness of Warfarin and Dabigatran Prescribed in the Non-Valvular Atrial Fibrillation Population With DoD Healthcare Coverage

Who this might be right for
Atrial Fibrillation
Boehringer Ingelheim 25,586
Not applicableNot Yet RecruitingNCT06969118
What this trial is testing

RCT of Minimalist vs Standard Procedure for LAAC in NVAF Patients

Who this might be right for
Atrial FibrillationLeft Atrial Appendage OcclusionGeneral Anesthesia+1 more
Shanghai Zhongshan Hospital 200
Not applicableStudy completedNCT02792335
What this trial is testing

Oral Anticoagulant Discontinuation, Adherence Patterns, Hospitalizations and Costs in Non-Valvular Atrial Fibrillation (NVAF) Patients

Who this might be right for
Atrial Fibrillation
Bristol-Myers Squibb 28,000
Not applicableStudy completedNCT03570047
What this trial is testing

Safety and Effectiveness of Oral Anticoagulants in Patients With Non-valvular Atrial Fibrillation

Who this might be right for
Non-valvular Atrial Fibrillation
Pfizer 73,989
Not applicableStudy completedNCT03189069
What this trial is testing

A Real-World Comparison of Safety and Effectiveness of Novel Oral Anti-Coagulant (NOAC) Naïve and Warfarin Naïve Non-Valvular Atrial Fibrillation (NVAF) Patients With Medicare Advantage Coverage

Who this might be right for
Atrial Fibrillation
Bristol-Myers Squibb 36,000
Next Page